Vertex Pharmaceuticals: R&D Portfolio Management (A) Harvard Case Solution & Analysis

Vertex Pharmaceuticals: R&D Portfolio Management (A) Case Solution

Vertex Pharmaceuticals, Inc., a drug discovery company that recently decided to pursue a vertically integrated business model, picked to build up its clinical development and commercial abilities and infrastructure.

For the very first time in its history, Vertex will pick two drug candidates from its internal research portfolio of four projects to develop by itself, without the aid of strategic partners. President Vicki Sato and CEO Joshua Boger are grappling with which two projects to choose. Furthermore, this note focuses on the way to handle the procedure for portfolio selection and how to select projects.

PUBLICATION DATE: June 10, 2004

This is just an excerpt. This case is about TECHNOLOGY & OPERATIONS

Vertex Pharmaceuticals: R&D Portfolio Management (A) Case Solution Other Similar Case Solutions like

Vertex Pharmaceuticals: R&D Portfolio Management (A)

Share This